• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Repligen Corporation - Common Stock (NQ:RGEN)

164.35 +0.49 (+0.30%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 639,918
Open 163.53
Bid (Size) 159.00 (200)
Ask (Size) 185.00 (2,000)
Prev. Close 163.86
Today's Range 162.21 - 167.50
52wk Range 102.97 - 182.52
Shares Outstanding 55,679,964
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
1 Volatile Stock to Target This Week and 2 We Turn Down
December 07, 2025
Market swings can be tough to stomach, and volatile stocks often experience exaggerated moves in both directions. While many thrive during risk-on environments, many also struggle to maintain investor... 
Via StockStory
News headline image
Why Repligen (RGEN) Stock Is Trading Up Today
November 21, 2025
Shares of biopharma manufacturing company Repligen Corporation (NASDAQ:RGEN) jumped 5.7% in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate... 
Via StockStory
Topics Artificial Intelligence Economy Stocks

Performance

YTD
N/A
N/A
1 Month
-1.3%
-1.3%
3 Month
+10.5%
+10.5%
6 Month
+32.1%
+32.1%
1 Year
+14.9%
+14.9%

More News

Read More
News headline image
Lantheus, Enovis, Evolent Health, Repligen, and Corcept Shares Are Soaring, What You Need To Know
November 11, 2025
Via StockStory
Topics Artificial Intelligence Stocks
News headline image
Earnings Scheduled For October 28, 2025 ↗
October 28, 2025
Via Benzinga
News headline image
3 Cash-Producing Stocks We Approach with Caution
November 10, 2025
Via StockStory
News headline image
Drug Development Inputs & Services Stocks Q3 Recap: Benchmarking Repligen (NASDAQ:RGEN)
November 06, 2025
Via StockStory
News headline image
5 Revealing Analyst Questions From Repligen’s Q3 Earnings Call
November 04, 2025
Via StockStory
Topics Earnings
News headline image
3 Hyped Up Stocks with Open Questions
October 30, 2025
Via StockStory
News headline image
RGEN Q3 Deep Dive: Robust Product Demand Offset by Margin Pressures and Guidance Reset
October 29, 2025
Via StockStory
News headline image
Why Repligen (RGEN) Shares Are Trading Lower Today
October 28, 2025
Via StockStory
Topics Economy Government World Trade
News headline image
Repligen Corp (NASDAQ:RGEN) Posts Strong Q3 2025 Results, Beating Revenue and EPS Estimates ↗
October 28, 2025
Via Chartmill
News headline image
Repligen’s (NASDAQ:RGEN) Q3 Sales Beat Estimates
October 28, 2025
Via StockStory
Topics Earnings
News headline image
Repligen Earnings: What To Look For From RGEN
October 26, 2025
Via StockStory
Topics Artificial Intelligence
News headline image
3 Inflated Stocks with Questionable Fundamentals
October 21, 2025
Via StockStory
News headline image
Myriad Genetics, Omnicell, Globus Medical, Repligen, and Teleflex Stocks Trade Down, What You Need To Know
October 10, 2025
Via StockStory
Topics Economy Government World Trade
News headline image
Federal Reserve Signals Further Rate Cuts Amidst Worsening Labor Market and Divided Opinions
October 14, 2025
Via MarketMinute
Topics Artificial Intelligence Bonds Credit Cards
News headline image
Thermo Fisher Scientific Soars on Strategic Wins, Market Optimism
October 01, 2025
Via MarketMinute
Topics Artificial Intelligence Economy Government
News headline image
What 8 Analyst Ratings Have To Say About Repligen ↗
October 01, 2025
Via Benzinga
News headline image
Why Is Repligen (RGEN) Stock Soaring Today
October 01, 2025
Via StockStory
Topics Government
News headline image
Repligen, BrightSpring Health Services, Danaher, Thermo Fisher, and Amgen Shares Skyrocket, What You Need To Know
September 30, 2025
Via StockStory
Topics Government
News headline image
1 Volatile Stock to Target This Week and 2 Facing Challenges
September 25, 2025
Via StockStory
News headline image
3 Reasons to Sell RGEN and 1 Stock to Buy Instead
September 24, 2025
Via StockStory
Topics Stocks
News headline image
Drug Development Inputs & Services Stocks Q2 Results: Benchmarking Repligen (NASDAQ:RGEN)
September 22, 2025
Via StockStory
News headline image
This Sarepta Therapeutics Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday ↗
September 22, 2025
Via Benzinga
News headline image
Small-Cap and Value Stocks Stage a Powerful Comeback: A Market Rebalancing Act Underway
September 19, 2025
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property

Frequently Asked Questions

Is Repligen Corporation - Common Stock publicly traded?
Yes, Repligen Corporation - Common Stock is publicly traded.
What exchange does Repligen Corporation - Common Stock trade on?
Repligen Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Repligen Corporation - Common Stock?
The ticker symbol for Repligen Corporation - Common Stock is RGEN on the Nasdaq Stock Market
What is the current price of Repligen Corporation - Common Stock?
The current price of Repligen Corporation - Common Stock is 164.35
When was Repligen Corporation - Common Stock last traded?
The last trade of Repligen Corporation - Common Stock was at 01/02/26 04:00 PM ET
What is the market capitalization of Repligen Corporation - Common Stock?
The market capitalization of Repligen Corporation - Common Stock is 9.15B
How many shares of Repligen Corporation - Common Stock are outstanding?
Repligen Corporation - Common Stock has 9B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap